They have successfully recruited 6 patients for the ongoing Phase 1 trial, with no observed side effects even at dosages up to six times higher than the therapeutic dose.
More on April 9 at AACR meeting
They have successfully recruited 6 patients for the ongoing Phase 1 trial, with no observed side effects even at dosages up to six times higher than the therapeutic dose.
More on April 9 at AACR meeting
Nice, but this appears to be for lung cancer...
It was sold as the miracle drug that can annihilate 70 different kinds of cancer….I am doubtful but at least it has not killed any patient yet! I think it was largely oversold at the beginning.
Of course more than willing to be proven wrong at any time!